Inventor
JAMES M. MCKEARIN
Inventor
US
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C07HSugars29%
A61KPreparations for medical, dental or toiletry purposes18%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium18%
C07DHeterocyclic compounds6%
PatentTitleYear
12,485,135Nicotinamide mononucleotide derivatives and their uses202511,939,348Compositions comprising a phosphorus derivative of nicotinamide riboside and methods for modulation of nicotinamide adenine dinucleotide202411,878,994Compositions for treatment of inflammation202411,878,027Nicotinamide mononucleotide derivatives and their uses202411,464,796Nicotinamide mononucleotide derivatives and their uses2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to METRO INT BIOTECH LLC (5)· patent assignee history
2022–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| METRO INT BIOTECH LLC | 5 | 2022–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 5 | 2022–2025 |